Profile
MDAI ABT BSX-PA SYK MDT BSX
Company Name Spectral AI, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $46.65M $197.70B $175.45B $137.02B $129.65B $108.96B
Employees 0.08K 114.00K 45.00K 53.00K 95.00K 53.00K
CEO Wensheng Fan Robert Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney
Ratings
MDAI ABT BSX-PA SYK MDT BSX
Quant Rating Score 2 2 3 3 1
Quant Rating Sell Sell Neutral Neutral Strong Sell
Trading
MDAI ABT BSX-PA SYK MDT BSX
Last Close $1.44 $130.03 $122.18 $360.13 $96.28 $101.76
High 52 $3.13 $140.22 $122.18 $403.53 $98.43 $108.14
Low 52 $1.06 $111.1 $122.18 $337.28 $79.61 $88.03
Price vs. 52 Week High -53.99 % -7.27 % 0 % -10.76 % -2.18 % -5.9 %
Price vs. 52 Week Low 35.85 % 17.04 % 0 % 6.77 % 20.94 % 15.6 %
Total Return
MDAI ABT BSX-PA SYK MDT BSX
1 Month Return -39.75 % 1.16 % 0 % -3.82 % 0.52 % 2.54 %
3 Month Return -32.08 % -0.18 % 0 % -5.68 % 3.74 % -1.25 %
6 Month Return 4.35 % -3.54 % 0 % -8.65 % 11.38 % -4.04 %
9 Month Return -26.53 % -0.12 % 0 % -6.61 % 11.86 % -3.41 %
YTD Return -49.12 % 14.96 % 0 % 0.02 % 20.53 % 13.93 %
1 Year Return 27.43 % 11.01 % 0 % -7.35 % 13.27 % 12.65 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MDAI ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.11 % - 0.95 % 2.8 % -
Dividend Paid and Capex Coverage Ration (TTM) -2.76 % 1.46 % 5.44 % 2.47 % 1.29 % 5.44 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % 2.83 % -
Payout Ratio (TTM) - 61.99 % - 39.56 % 75.84 % -
Growth
MDAI ABT BSX-PA SYK MDT BSX
Asset Growth 13.12 % - 11.34 % 1.89 % 12.12 %
Gross Profit Growth 68.45 % 15.39 % 10.39 % 3.58 % 16.26 %
Revenue Growth 63.83 % 5.67 % 11.16 % 3.62 % 17.61 %
Revenue 3 Year 93.53 % 1.9 % 34.71 % 10.52 % 36.16 %
Revenue 5 Year - 29.99 % 71.94 % 20.96 % 47.52 %
Revenue 10 Year - 83.13 % 148.82 % 41.05 % 104.22 %
EBIT Growth 42.05 % 12.74 % 15.72 % 14.42 % 18.25 %
Net Income Growth 26.56 % -51.32 % 8.45 % 26.82 % 16.38 %
Net Income 3 Yeari Growth Per Share -282.87 % -5.58 % 36.22 % -3.39 % 72.31 %
Net Income 5 Yeari Growth Per Share - 47.3 % 99.44 % 1.52 % -62.7 %
Net Income 10 Yeari Growth Per Share - 24.34 % 122.27 % 48.51 % 1502.13 %
Operating Income Growth 49.31 % 17.92 % 11.14 % 15.77 % 20.82 %
Operating Cash Flow Growth (CFG) 30.52 % - 18.91 % 3.79 % 37.24 %
Operating 3 Year CFG -214.3 % -100 % 90.21 % 0.13 % 77.55 %
Operating 5 Year CFG - -100 % 51.22 % 1.55 % 76.92 %
Operating 10 Year CFG - -100 % 452.85 % 22.45 % 143.61 %
EPS Growth 42.57 % -51.24 % 8.02 % 31.05 % 16.61 %
EPS Diluted Growth 42.57 % -51.31 % 8.25 % 30.8 % 16.52 %
Book Value Per Share -233.28 % -100 % 8.31 % -1.16 % 11.25 %
Share Holder 3 Year Equity Growth Per Share -152.56 % -100 % 33.52 % -4.58 % 26.58 %
Share Holder 5 Year Equity Growth Per Share - -100 % 68.35 % -1.29 % 48.35 %
Share Holder 10 Year Equity Growth Per Share - -100 % 159.56 % -23.12 % 186.31 %
Dividend Per Share Growth - 6.54 % 5 % 1.11 % -100 %
Dividend 3 Year Growth Per Share - 25.03 % 20.89 % 10.78 % -100 %
Dividend 5 Year Growth Per Share - 63.45 % 46.18 % 29.33 % -
Dividend 10 Year Growth Per Share - 140.85 % 142.84 % 128.74 % -
Debt Growth 263.85 % - 5.23 % 13.95 % 17.44 %
Free Cash Flow Growth 30.52 % - 22.83 % -0.29 % 55.31 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2025 30 Apr 2025 31 Dec 2024
Profitability
MDAI ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM 45.01 % 55.51 % 69.01 % 63.54 % 62.27 % 69.01 %
Return on Assets TTM -106.96 % 7.75 % 6.77 % 6.78 % 5.22 % 6.77 %
Return on Equity TTM 249.55 % 13.18 % 12.87 % 15.04 % 9.83 % 12.87 %
Return on Capital Employed TTM 1606.67 % 11.56 % 10.62 % 14.07 % 7.63 % 10.62 %
Net Income Per EBT TTM 101.22 % 77.06 % 85.38 % 71.91 % 83.61 % 85.38 %
EBT Per Ebit TTM 216.41 % 105.19 % 85.24 % 80.09 % 91.74 % 85.24 %
EBIT Per Revenue TTM -32.25 % 18.16 % 19.78 % 22.44 % 17.87 % 19.78 %
Cash Flow To Debt Ratio TTM -71.38 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Receivables Turnover TTM 23.4 4.26 7.1 6.22 5.44 7.1
Payables Turnover TTM 5.02 4.78 6.21 - 5.08 6.21
Inventory Turnover TTM 28.06 2.94 2.13 1.72 2.13 2.13
Fixed Asset Turnover TTM 1261.19 % 385.33 % 468.06 % 647.99 % 485.18 % 468.06 %
Asset Turnover TTM 151.42 % 52.66 % 47.01 % 52.5 % 38.05 % 47.01 %
Operating Cash Flow Per Share TTM -0.26 5.22 3.12 13.19 5.55 3.12
Free Cash Flow Per Share TTM -0.17 3.96 2.55 11.2 4.06 2.55
Cash Per Share TTM 39.88 % 442.64 % 85.99 % 1071.9 % 649.63 % 85.99 %
Operating Cash Flow Sales Ratio TTM -29.78 % 20.57 % 23.04 % 20.08 % 20.46 % 23.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 63.75 % 75.85 % 81.6 % 84.91 % 73.19 % 81.6 %
Cash Flow Coverage Ratios TTM -71.38 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Price To Free Cash Flows Ratio TTM -10.61 28.58 29.17 31.99 24.9 28.86
Price To Operating Cash Flows Ratio TTM -5.8 21.76 23.8 27.17 18.22 23.55
Price Cash Flow Ratio TTM -5.8 21.76 23.8 27.17 18.22 23.55
Income Statement (TTM)
MDAI ABT BSX-PA SYK MDT BSX
Revenue $0.03B $44.33B $20.07B $25.12B $33.54B $20.07B
Gross Profit $0.01B $24.61B $13.85B $15.43B $21.91B $13.85B
Gross Profit Ratio 44.87% 55.51% 69.01% 61.44% 65.32% 69.01%
EBITDA $-0.01B $11.33B $3.73B $5.69B $9.22B $3.73B
Net Income $-0.02B $6.52B $2.89B $3.25B $4.66B $2.89B
EPS Diluted -0.85 3.72 1.94 8.4 3.61 1.94
Balance Sheet (MRQ)
MDAI ABT BSX-PA SYK MDT BSX
Long Term Debt $0B $13.52B $9.37B $14.86B $25.64B $9.37B
Total Liabilities $0.02B $33.51B $17.39B $25.42B $43.42B $17.39B
Total Equity $-0.01B $47.9B $22B $22.42B $48.26B $22B
Total Investments $0B $1.24B $0.56B $0.09B $6.75B $0.56B
Total Debt $0B $15.28B $11.15B $14.86B $28.52B $11.15B
Total Assets $0.01B $81.41B $39.4B $47.84B $91.68B $39.4B
Cash Flow Statement (TTM)
MDAI ABT BSX-PA SYK MDT BSX
Net Income $-0.02B $13.4B $1.85B $3.25B $4.69B $1.85B
Inventory $-0B $-0.06B $-0.23B $0B $-0.29B $-0.23B
Dividends Paid $0B $-3.84B $0B $-1.28B $-3.59B $0B
Operating Cash Flow $-0.01B $8.56B $3.44B $5.04B $7.04B $3.44B
Capital Expenditure $0B $-2.21B $-0.79B $-0.76B $-1.86B $-0.79B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 111.5
ADGM Adagio Medical Holdings, Inc. 1.02
AEMD Aethlon Medical, Inc. 2
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 10.09
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 183.9
ALUR Allurion Technologies Inc. 1.08
AMIX Autonomix Medical, Inc. Common Stock 0.38
ANIK Anika Therapeutics, Inc. 10.06
AORT Artivion, Inc. 40.68
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.84
ARAY Accuray Incorporated 0.5367
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.08
AVNS Avanos Medical, Inc. 14.76
AVR Anteris Technologies Global Corp. Common Stock 5.68
AXDX Accelerate Diagnostics, Inc. 0.034
ETFs With Exposure to MDAI
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00003 336.15
VXF Vanguard Extended Market Index Fund 0.00034 213.895
IWC iShares Micro-Cap ETF 0.01 164.58
VUN.TO Vanguard U.S. Total Market Index ETF 0.00003 124.31
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00003 116.64
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 43.93
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00002 55.12
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.61
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 32.01
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.34
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.94
VTSAX Vanguard Total Stock Market Index Fund 0.00003 166.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00034 165.55
VITSX Vanguard Total Stock Market Index Fund 0.00003 166.27
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00034 165.56
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 481.52
VEMPX Vanguard Extended Market Index InstlPlus 0.00034 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 311.9
Unlock